TCM
TimesSquare Capital Management’s Royalty Pharma RPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,257,195
| Closed | -$38.6M | – | 174 |
|
2023
Q2 | $38.6M | Sell |
1,257,195
-10,635
| -0.8% | -$327K | 0.55% | 76 |
|
2023
Q1 | $45.7M | Sell |
1,267,830
-278,230
| -18% | -$10M | 0.67% | 60 |
|
2022
Q4 | $61.1M | Sell |
1,546,060
-18,840
| -1% | -$745K | 0.87% | 36 |
|
2022
Q3 | $62.9M | Sell |
1,564,900
-42,900
| -3% | -$1.72M | 0.87% | 27 |
|
2022
Q2 | $67.6M | Sell |
1,607,800
-43,100
| -3% | -$1.81M | 0.94% | 22 |
|
2022
Q1 | $64.3M | Sell |
1,650,900
-2,500
| -0.2% | -$97.4K | 0.72% | 42 |
|
2021
Q4 | $65.9M | Buy |
1,653,400
+133,400
| +9% | +$5.32M | 0.58% | 72 |
|
2021
Q3 | $54.9M | Buy |
1,520,000
+18,440
| +1% | +$666K | 0.48% | 84 |
|
2021
Q2 | $61.5M | Buy |
1,501,560
+85,945
| +6% | +$3.52M | 0.5% | 81 |
|
2021
Q1 | $61.7M | Sell |
1,415,615
-191,865
| -12% | -$8.37M | 0.53% | 76 |
|
2020
Q4 | $80.5M | Buy |
1,607,480
+618,970
| +63% | +$31M | 0.65% | 47 |
|
2020
Q3 | $41.6M | Buy |
988,510
+237,710
| +32% | +$10M | 0.39% | 114 |
|
2020
Q2 | $36.5M | Buy |
+750,800
| New | +$36.5M | 0.35% | 132 |
|